Skip to main content
OpenTrials

Clinical trial condition

Leukaemia, Lymphocytic, Chronic

Explore clinical trials studying Leukaemia, Lymphocytic, Chronic. Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Leukaemia, Lymphocytic, Chronic trial results

Completed

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

NCT00824265

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Novartis Investigative Site Boca Raton, Florida, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Clinton, Maryland, United States
  • Novartis Investigative Site Kansas City, Missouri, United States
View all 135 locations
View Trial Details
Completed

A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia

NCT01077622

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Kanagawa, Japan
  • GSK Investigational Site Nagasaki, Japan
  • GSK Investigational Site Tokyo, Japan
View Trial Details
Completed

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

NCT01520922

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations
  • Novartis Investigative Site Tuscon, Arizona, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Fort Myers, Florida, United States
  • Novartis Investigative Site St. Petersburg, Florida, United States
View all 33 locations
View Trial Details
Completed

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia

NCT01563055

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Hokkaido, Japan
  • GSK Investigational Site Kanagawa, Japan
  • GSK Investigational Site Kyoto, Japan
View Trial Details

Related conditions